Kod ATC L01
| Kod ATC L: Agen antineoplastik dan imunopemodulat |
|---|
| Kod ATC lain |
Kod ATC L01 Agen antineoplastik ialah subkumpulan terapeutik Sistem Pengelasan Bahan Kimia Terapeutik Anatomi, sistem kod huruf-nombor yang dibangunkan oleh Pertubuhan Kesihatan Sedunia (WHO) untuk mengelaskan ubat dan produk perubatan lain.[1][2][3] Subkumpulan L01 ialah sebahagian daripada kod anatomi L Antineoplastik dan agen imunomodulasi.[4]
Kod kegunaan veterinar (Kod ATCvet) boleh dihasilkan dengan meletakkan huruf Q di hadapan kod ATC manusia: contohnya, QL01.[5] Kod ATCvet tanpa kod ATC manusia dipetik dengan huruf awalan Q dalam senarai.
Pengelasan ATC peringkat kebangsaan mungkin memiliki kod tambahan yang tidak ada dalam senarai ini yang menuruti versi WHO.
L01A Agen pengalkilan
[sunting | sunting sumber]L01AA Analog mustard nitrogen
[sunting | sunting sumber]- L01AA01 Siklofosfamida
- L01AA02 Klorambusil
- L01AA03 Melfalan
- L01AA05 Klormetina
- L01AA06 Ifosfamida
- L01AA07 Trofosfamida
- L01AA08 Prednimustina
- L01AA09 Bendamustina
- L01AA10 Melfalan flufenamida
L01AB Sulfonat alkil
[sunting | sunting sumber]- L01AB01 Busulfan
- L01AB02 Treosulfan
- L01AB03 Manosulfan
L01AC Imina etilena
[sunting | sunting sumber]- L01AC01 Tiotepa
- L01AC02 Triazikuon
- L01AC03 Karbokuon
L01AD Nitrosourea
[sunting | sunting sumber]- L01AD01 Karmustina
- L01AD02 Lomustina
- L01AD03 Semustina
- L01AD04 Streptozosin
- L01AD05 Fotemustina
- L01AD06 Nimustina
- L01AD07 Ranimustina
- L01AD08 Uramustina
L01AG Epoksida
[sunting | sunting sumber]- L01AG01 Etoglusid
L01AX Agen pengalkilan lain
[sunting | sunting sumber]- L01AX01 Mitobronitol
- L01AX02 Pipobroman
- L01AX03 Temozolomida
- L01AX04 Dakarbazina
L01B Antimetabolit
[sunting | sunting sumber]L01BA Analog asid folik
[sunting | sunting sumber]- L01BA01 Metotreksat
- L01BA03 Raltitreksed
- L01BA04 Pemetreksed
- L01BA05 Pralatreksat
L01BB Analog purina
[sunting | sunting sumber]- L01BB02 Merkaptopurina
- L01BB03 Tioguanina
- L01BB04 Kladribina
- L01BB05 Fludarabina
- L01BB06 Klofarabina
- L01BB07 Nelarabina
- QL01BB90 Rabakfosadina
L01BC Analog pirimidina
[sunting | sunting sumber]- L01BC01 Sitarabina
- L01BC02 Fluorourasil
- L01BC03 Tegafur
- L01BC04 Karmofur
- L01BC05 Gemsitabina
- L01BC06 Capesitabina
- L01BC07 Azasitidina
- L01BC08 Desitabina
- L01BC09 Floksuridina
- L01BC52 Fluorourasil, campuran
- L01BC53 Tegafur, campuran
- L01BC58 Desitabine, campuran
- L01BC59 Trifluridina, campuran
L01C Alkaloid tumbuhan dan produk semula jadi lain
[sunting | sunting sumber]L01CA Alkaloid vinka dan analog
[sunting | sunting sumber]- L01CA01 Vinblastina
- L01CA02 Vinkristina
- L01CA03 Vindesina
- L01CA04 Vinorelbina
- L01CA05 Vinflunina
- L01CA06 Vintafolida
L01CB Terbitan podofilotoksin
[sunting | sunting sumber]- L01CB01 Etoposida
- L01CB02 Teniposida
L01CC Terbitan kolkisina
[sunting | sunting sumber]- L01CC01 Demekolsina
L01CD Taksana
[sunting | sunting sumber]- L01CD01 Paklitaksel
- L01CD02 Dosetaksel
- L01CD03 Paklitaksel poliglumeks
- L01CD04 Kabazitaksel
- L01CD51 Paklitaksel dan ensekuidar
L01CE Perencat topoisomerase 1 (TOP1)
[sunting | sunting sumber]- L01CE01 Topotekan
- L01CE02 Irinotekan
- L01CE03 Etirinotekan pegol
- L01CE04 Belotekan
L01CX Alkaloid tumbuhan dan produk semula jadi lain
[sunting | sunting sumber]- L01CX01 Trabektedin
L01D Antibiotik sitotoksin dan bahan berkaitan
[sunting | sunting sumber]L01DA Actinomisin
[sunting | sunting sumber]- L01DA01 Daktinomisin
L01DB Anthracyclines and related substances
[sunting | sunting sumber]- L01DB01 Doksorubisin
- L01DB02 Daunorubisin
- L01DB03 Epirubisin
- L01DB04 Aklarubisin
- L01DB05 Zorubisin
- L01DB06 Idarubisin
- L01DB07 Mitoksantron
- L01DB08 Pirarubisin
- L01DB09 Valrubisin
- L01DB10 Amrubisin
- L01DB11 Piksantron
L01DC Antibiotik sitotoksin lain
[sunting | sunting sumber]- L01DC01 Bleomisin
- L01DC02 Plikamisin
- L01DC03 Mitomisin
- L01DC04 Iksabepilon
L01E Perencat kinase protein
[sunting | sunting sumber]L01EA Perenat kinase tirosina BCR-ABL
[sunting | sunting sumber]- L01EA01 Imatinib
- L01EA02 Dasatinib
- L01EA03 Nilotinib
- L01EA04 Bosutinib
- L01EA05 Ponatinib
- L01EA06 Asiminib
L01EB Perencat kinase tirosina reseptor faktor pertumbuhan epidermis (EGFR)
[sunting | sunting sumber]- L01EB01 Gefitinib
- L01EB02 Erlotinib
- L01EB03 Afatinib
- L01EB04 Osimertinib
- L01EB05 Rosiletinib
- L01EB06 Olmutinib
- L01EB07 Dakomitinib
- L01EB08 Ikotinib
- L01EB09 Lazertinib
- L01EB10 Mobosertinib
- L01EB11 Aumolertinib
L01EC Perenacat kinase serina-treonina B-Raf (BRAF)
[sunting | sunting sumber]- L01EC01 Vemurafenib
- L01EC02 Dabrafenib
- L01EC03 Enkorafenib
L01ED Perencat kinase limfona anaplastik (ALK)
[sunting | sunting sumber]- L01ED01 Krizotinib
- L01ED02 Seritinib
- L01ED03 Alektinib
- L01ED04 Brigatinib
- L01ED05 Lorlatinib
L01EE Perencat kinase protein diaktifkan mitogen (MEK)
[sunting | sunting sumber]- L01EE01 Trametinib
- L01EE02 Kobimetinib
- L01EE03 Binimetinib
- L01EE04 Selumetinib
L01EF Perencat kinase bergantungan siklin (CDK)
[sunting | sunting sumber]- L01EF01 Palbosiklib
- L01EF02 Ribosiklib
- L01EF03 Abemasiklib
L01EG Perencat kinase sasaran rapamisin mamalia (mTOR)
[sunting | sunting sumber]- L01EG01 Temsirolimus
- L01EG02 Everolimus
- L01EG03 Ridaforolimus
- L01EG04 Sirolimus
L01EH Perencat kinase tirosina reseptor faktor pertumbuhan epidermis manusia 2 (HER2)
[sunting | sunting sumber]L01EJ Perencat kinase berkaitan Janus (JAK)
[sunting | sunting sumber]- L01EJ01 Ruksolitinib
- L01EJ02 Fedratinib
- L01EJ03 Pakritinib
- L01EJ04 Momelotinib
L01EK Perencat kinase tirosina reseptor faktor pertumbuhan endotelium vaskular (VEGFR)
[sunting | sunting sumber]- L01EK01 Aksitinib
- L01EK02 Sediranib
- L01EK03 Tivozanib
- L01EK04 Frukuintinib
L01EL Perencat kinase tirosina Bruton (BTK)
[sunting | sunting sumber]- L01EL01 Ibrutinib
- L01EL02 Akalabrutinib
- L01EL03 Zanubrutinib
- L01EL04 Orelabrutinib
- L01EL05 Pirtobrutinib
L01EM Perencat fosfatidilinositol-3-kinase (Pi3K)
[sunting | sunting sumber]- L01EM01 Idelalisib
- L01EM02 Kopanlisib
- L01EM03 Alpelisib
- L01EM04 Duvelisib
- L01EM05 Parsaklisib
L01EN Perencat kinase tirosina reseptor faktor pertumbuhan fibroblas (FGFR)
[sunting | sunting sumber]- L01EN01 Erdafitinib
- L01EN02 Pemigatinib
- L01EN03 Infigratinib
- L01EN04 Futibatinib
L01EX Perencat kinase protein lain
[sunting | sunting sumber]- L01EX01 Sunitinib
- L01EX02 Sorafenib
- L01EX03 Pazopanib
- L01EX04 Vandetanib
- L01EX05 Regorafenib
- L01EX06 Masitinib
- L01EX07 Kabozantinib
- L01EX08 Lenvatinib
- L01EX09 Nintedanib
- L01EX10 Midostaurin
- L01EX11 Kuizartinib
- L01EX12 Larotrektinib
- L01EX13 Gilteritinib
- L01EX14 Entrektinib
- L01EX15 Peksidartinib
- L01EX17 Kapmatinib
- L01EX18 Avapritinib
- L01EX19 Ripretinib
- L01EX21 Tepotinib
- L01EX22 Selperkatinib
- L01EX23 Pralsetinib
- L01EX24 Surufatinib
- L01EX25 Umbralisib
- L01EX26 Sitravatinib
- L01EX27 Kapivasertib
- QL01EX90 Toseranib
L01F Antibodi monoklon dan konjugat ubat antibodi
[sunting | sunting sumber]L01FA Perencat CD20 (kluster pembezaan 20)
[sunting | sunting sumber]- L01FA01 Rituksimab
- L01FA02 Ofatumumab
- L01FA03 Obinutuzumab
L01FB Perencat CD22 (kluster pembezaan 22)
[sunting | sunting sumber]- L01FB01 Inotuzumab ozogamisin
- L01FB02 Moksetumomab pasudotoks
L01FC Perencat CD38 (kluster pembezaan 38)
[sunting | sunting sumber]- L01FC01 Daratumumab
- L01FC02 Isatuksimab
L01FD Perencat HER2 (reseptor faktor pertumbuhan epidermis manusia 2)
[sunting | sunting sumber]- L01FD01 Trastuzumab
- L01FD02 Pertuzumab
- L01FD03 Trastuzumab emtansina
- L01FD04 Trastuzumab derukstekan
- L01FD05 Trastuzumab duokarmazina
- L01FD06 Margetuksimab
L01FE Perencat EGFR (reseptor faktor pertumbuhan epidermis)
[sunting | sunting sumber]- L01FE01 Setuksimab
- L01FE02 Panitumumab
- L01FE03 Nesitumumab
L01FF Perencat PD-1/PDL-1 (protein kematian sel berencana 1/ligan kematian 1)
[sunting | sunting sumber]- L01FF01 Nivolumab
- L01FF02 Pembrolizumab
- L01FF03 Durvalumab
- L01FF04 Avelumab
- L01FF05 Atezolizumab
- L01FF06 Semiplimab
- L01FF07 Dostarlimab
- L01FF08 Prolgolimab
- L01FF09 Tislelizumab
- L01FF10 Retifanlimab
- L01FF11 Sugemalimab
- L01FF12 Serplulimab
- L01FF13 Toripalimab
L01FG Perencat VEGF/VEGFR (faktor pertumbuhan endotelium vaskular)
[sunting | sunting sumber]- L01FG01 Bevasizumab
- L01FG02 Ramusirumab
L01FX Antibodi monoklon dan konjugat ubat antibodi lain
[sunting | sunting sumber]- L01FX01 Edrekolomab
- L01FX02 Gemtuzumab ozogamisin
- L01FX03 Katumaksomab
- L01FX04 Ipilimumab
- L01FX05 Brentuksimab vedotin
- L01FX06 Dinutuksimab beta
- L01FX07 Blinatumomab
- L01FX08 Elotuzumab
- L01FX09 Mogamulizumab
- L01FX10 Olaratumab
- L01FX11 Bermekimab
- L01FX12 Tafasitamab
- L01FX13 Enfortumab vedotin
- L01FX14 Polatuzumab vedotin
- L01FX15 Belantamab mafodotin
- L01FX16 Oportuzumab monatoks
- L01FX17 Sakituzumab govitekan
- L01FX18 Amivantamab
- L01FX19 Sabatolimab
- L01FX20 Tremelimumab
- L01FX21 Naxitamab
- L01FX22 Lonkastuksimab tesirina
- L01FX23 Tisotumab vedotin
- L01FX24 Teklistamab
- L01FX25 Mosunetuzumab
- L01FX26 Mirvetuksimab soravtansina
- L01FX27 Epkoritamab
- L01FX28 Glofitamab
- L01FX29 Talkuetamab
L01FY Campuran antibodi monoklon dan konjugat ubat antibodi
[sunting | sunting sumber]- L01FY01 Pertuzumab dan trastuzumab
- L01FY02 Nivolumab dan relatlimab
- L01FY03 Prolgolimab dan nurulimab
L01X Agen antineoplastik lain
[sunting | sunting sumber]L01XA Sebatian platinum
[sunting | sunting sumber]- L01XA01 Sisplatin
- L01XA02 Karboplatin
- L01XA03 Oksaliplatin
- L01XA04 Satraplatin
- L01XA05 Poliplatilen
L01XB Metilhidrazina
[sunting | sunting sumber]- L01XB01 Prokarbazina
L01XD Pemeka terapi fotodinamik/sinaran
[sunting | sunting sumber]- L01XD01 Natrium porfimer
- L01XD03 Metil aminolevulinat
- L01XD04 Asid aminolevulinik
- L01XD05 Temoporfin
- L01XD06 Efaproksiral
- L01XD07 Padeliporfin
L01XF Retinoid rawatan kanser
[sunting | sunting sumber]- L01XF01 Tretinoin
- L01XF02 Alitretinoin
- L01XF03 Beksarotena
L01XG Perencat proteasom
[sunting | sunting sumber]- L01XG01 Bortezomib
- L01XG02 Karfilzomib
- L01XG03 Iksazomib
L01XH Perencat deasetilase histon (HDAC)
[sunting | sunting sumber]- L01XH01 Vorinostat
- L01XH02 Romidepsin
- L01XH03 Panobinostat
- L01XH04 Belinostat
- L01XH05 Entinostat
L01XJ Perencat laluan hedgehog
[sunting | sunting sumber]- L01XJ01 Vismodegib
- L01XJ02 Sonidegib
- L01XJ03 Glasdegib
L01XK Perencat polimerase poli-(ADP-ribosa) (PARP)
[sunting | sunting sumber]- L01XK01 Olaparib
- L01XK02 Niraparib
- L01XK03 Rukaparib
- L01XK04 Talazoparib
- L01XK05 Veliparib
- L01XK06 Pamiparib
- L01XK52 Niraparib dan abirateron
L01XL Sel antineoplastik dan terapi gen
[sunting | sunting sumber]- L01XL01 Sitimagen seradenovek
- L01XL02 Talimogen laherparepvek
- L01XL03 Aksikabtagen siloleusel
- L01XL04 Tisagenlekleusel
- L01XL05 Siltakabtagen autoleusel
- L01XL06 Breksukabtagen autoleusel
- L01XL07 Idekabtagen vikleusel
- L01XL08 Lisokabtagen maraleusel
- L01XL09 Tabelekleusel
- L01XL10 Nadofaragen firadenovek
- L01XL11 Lifileusel
L01XX Agen antineoplastik lain
[sunting | sunting sumber]- L01XX01 Amsakrina
- L01XX02 Asparaginase
- L01XX03 Altretamina
- L01XX05 Hidroksikarbamida
- L01XX07 Lonidamina
- L01XX08 Pentostatin
- L01XX10 Masoprokol
- L01XX11 Estramustina
- L01XX16 Mitoguazon
- L01XX18 Tiazofurina
- L01XX23 Mitotana
- L01XX24 Pegaspargase
- L01XX27 Arsenik trioksida
- L01XX29 Denileukin diftitoks
- L01XX33 Selekoksib
- L01XX35 Anagrelida
- L01XX36 Oblimersen
- L01XX40 Omasetaksina mepesuksinat
- L01XX41 Eribulin
- L01XX44 Aflibersept
- L01XX46 Olaparib
- L01XX52 Venetoclaks
- L01XX53 Vosaroksin
- L01XX57 Plitidepsin
- L01XX58 Epakadostat
- L01XX59 Enasidenib
- L01XX62 Ivosidenib
- L01XX66 Selineksor
- L01XX67 Tagraksofusp
- L01XX69 Lurbinektedin
- L01XX72 Tazemetostat
- L01XX73 Sotorasib
- L01XX74 Belzutifan
- L01XX75 Tebentafusp
- L01XX77 Adagrasib
- L01XX78 Navitoklaks
- L01XX79 Eflornitina
- L01XX80 Imetelstat
- QL01XX91 Tigilanol tiglat
- QL01XX92 Verdineksor
L01XY Campuran agen antineoplastik
[sunting | sunting sumber]- L01XY01 Sitarabina dan daunorubisin
Rujukan
[sunting | sunting sumber]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". Institut Kesihatan Kebangsaan. Dicapai pada 1 Februari 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". Pertubuhan Kesihatan Sedunia. Dicapai pada 3 Januari 2022.
- ^ "Structure and principles". Pusat Kerjasama Metodologi Statistik Dadah WHO. 15 Februari 2018. Dicapai pada 3 Januari 2022.
- ^ "ATC/DDD Index 2022: code L01" (dalam bahasa Inggeris). Pusat Kerjasama Metodologi Statistik Dadah WHO.
- ^ "ATCvet Index 2022: code QL01". Pusat Kerjasama Metodologi Statistik Dadah WHO.